Institutional shares held 15.6 Million
981K calls
521K puts
Total value of holdings $117M
$7.35M calls
$3.9M puts
Market Cap $216M
28,891,900 Shares Out.
Institutional ownership 53.94%
# of Institutions 77


Latest Institutional Activity in CADL

Top Purchases

Q4 2024
Baker Bros. Advisors LP Shares Held: 2.98M ($22.3M)
Q4 2024
Acorn Capital Advisors, LLC Shares Held: 1.94M ($14.5M)
Q4 2024
Braidwell LP Shares Held: 1.6M ($12M)
Q4 2024
Portolan Capital Management, LLC Shares Held: 754K ($5.65M)
Q4 2024
Vanguard Group Inc Shares Held: 1.34M ($10M)

Top Sells

Q4 2024
Simplex Trading, LLC Shares Held: 4.57K ($34.2K)
Q4 2024
Jane Street Group, LLC Shares Held: 16.6K ($124K)
Q4 2024
Bridgeway Capital Management, LLC Shares Held: 77.2K ($578K)
Q4 2024
Vontobel Holding Ltd. Shares Held: 19K ($142K)
Q4 2024
Royal Bank Of Canada Shares Held: 531 ($3.98K)

About CADL

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. It also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. The company was incorporated in 2003 and is based in Needham, Massachusetts.


Insider Transactions at CADL

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1.32M Shares
From 4 Insiders
Open market or private purchase 1.25M shares
Sale (or disposition) back to the issuer 50K shares
Open market or private sale 6.21K shares
Exercise of conversion of derivative security 12.9K shares
Sell / Disposition
2.05M Shares
From 7 Insiders
Open market or private sale 451K shares
Sale (or disposition) back to the issuer 1.6M shares

Track Institutional and Insider Activities on CADL

Follow Candel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

News

Receive news related to Candel Therapeutics, Inc.

Track Activities on CADL